US panel review for Seroquel paediatric indications
31 March 2009
Sue Sutter
Please Login to read the full article.
31 March 2009
Sue Sutter
sue.sutter@informa.com
AstraZeneca said the US FDA's psychopharmacologic drugs advisory committee will convene on June 9th-10th to consider the first paediatric indications for the atypical antipsychotic Seroquel (quetiapine fumarate).
Last year the company filed sNDAs for acute treatment of schizophrenia in adolescents...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Abilify gains US approval for adjunctive maintenance use in bipolar disorder
- Mixed results for AstraZeneca in Scotland while patient access scheme swings yes for Pfizer
- 2012 patent expiries will undermine pharma industry
- AstraZeneca tries to plug development gap with two Asian deals
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
